Bjorn Fraser Olaisen

Aging researcher and founder building mitochondrial export therapeutics

bjornolaisen

Cambridge, England

Joined May 2026

Summary

PhD researcher focused on epigenomics and cellular rejuvenation — technically oriented and method-driven. ac+2

Founder and startup-builder translating academic ideas into a therapeutics company (MitoExport) aimed at programmable mitochondrial export. mitoexport+1

Cross-disciplinary hands-on lab experience across leading labs (Harvard Sinclair Lab, Evandro Fang Lab) informing translational ambitions. bit+1

Public communicator advocating for longevity science through media and podcasts. apple+2

Work

Education

Projects

Writing

Replacement-Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions

January 1, 2026

A long-form piece discussing replacement-based ageing interventions as strategies for systemic rejuvenation and clinical translation, arguing for broad synthetic or replacement approaches to reverse diverse age-related damage.

onlinelibrary.wiley.com

Bjorn Fraser Olaisen

Summary

Work

PhD student (Medical Science) — Epigenetics, Ageing, and RejuvenationUniversity of Cambridge (Balasubramanian Lab) / Trinity College2023–Present

Company-seeding fellow, Bio-sparkUniversity of Cambridge / Cambridge Gravity (Bio-Spark)2024–Present

Longevity Nexus memberNorn Group2025–Present

5050 UK fellow (Cohort 1)Fifty Years / 5050 UK2025–Present

Exploring fellow, Bio-sparkUniversity of Cambridge / Cambridge Gravity (Bio-Spark)2023–2024

Faculty of Life Sciences and Medicine RepresentativeKing’s Biotechnology and Synthetic Biology Society (King's College London)2022–2023

Final year research project (Bachelor)King's College London2023–2023

Research InternSinclair Lab, Harvard Medical School2022–2022

Research AssistantEvandro Fang Lab, University of Oslo2021–2021

Education

PhD in Medical Science (Epigenetics, Ageing, and Rejuvenation)University of Cambridge (Trinity College)2023–Present

BSc Molecular Genetics (three-year degree)King's College London

Projects

MitoExporter technology (programmable mitochondrial export)2023–Present

Company-building through 5050 UK and Bio-Spark2024–Present

Writing

Replacement-Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions